JP2020521784A5 - - Google Patents

Download PDF

Info

Publication number
JP2020521784A5
JP2020521784A5 JP2019565921A JP2019565921A JP2020521784A5 JP 2020521784 A5 JP2020521784 A5 JP 2020521784A5 JP 2019565921 A JP2019565921 A JP 2019565921A JP 2019565921 A JP2019565921 A JP 2019565921A JP 2020521784 A5 JP2020521784 A5 JP 2020521784A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
group
orn
functional variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019565921A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020521784A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/064355 external-priority patent/WO2018220123A1/en
Publication of JP2020521784A publication Critical patent/JP2020521784A/ja
Publication of JP2020521784A5 publication Critical patent/JP2020521784A5/ja
Pending legal-status Critical Current

Links

JP2019565921A 2017-05-31 2018-05-31 長時間作用性ｇｉｐペプチド類似体 Pending JP2020521784A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17173628.3 2017-05-31
EP17173628 2017-05-31
PCT/EP2018/064355 WO2018220123A1 (en) 2017-05-31 2018-05-31 Long-acting gip peptide analogues

Publications (2)

Publication Number Publication Date
JP2020521784A JP2020521784A (ja) 2020-07-27
JP2020521784A5 true JP2020521784A5 (https=) 2021-07-26

Family

ID=59021262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019565921A Pending JP2020521784A (ja) 2017-05-31 2018-05-31 長時間作用性ｇｉｐペプチド類似体

Country Status (10)

Country Link
US (1) US11572399B2 (https=)
EP (2) EP3630806B1 (https=)
JP (1) JP2020521784A (https=)
KR (1) KR102743887B1 (https=)
CN (1) CN110691788B (https=)
AU (1) AU2018276434B2 (https=)
BR (1) BR112019025195A8 (https=)
ES (1) ES2972848T3 (https=)
PL (1) PL3630806T3 (https=)
WO (1) WO2018220123A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10968266B2 (en) 2014-09-05 2021-04-06 University Of Copenhagen GIP peptide analogues
PL3630806T3 (pl) 2017-05-31 2024-05-13 The University Of Copenhagen Analogi peptydów gip o długotrwałym działaniu
KR102379958B1 (ko) 2018-05-04 2022-04-01 노보 노르디스크 에이/에스 Gip 유도체 및 이의 용도
CN121449721A (zh) * 2018-12-03 2026-02-03 安泰博医药 经修饰的gip肽类似物
CA3157387A1 (en) * 2019-12-03 2021-06-10 Mette Marie Rosenkilde Optimized gip peptide analogues
WO2023139106A2 (en) 2022-01-18 2023-07-27 Novo Nordisk A/S Long-acting gipr antagonists

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869602A (en) 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6268343B1 (en) 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6384016B1 (en) 1998-03-13 2002-05-07 Novo Nordisk A/S Stabilized aqueous peptide solutions
WO1998024464A1 (en) 1996-12-03 1998-06-11 Trustees Of Boston University Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
DE69900026T2 (de) 1998-01-30 2001-05-10 Novo Nordisk As Eine injektionsspritze
JP2003522099A (ja) 1998-02-27 2003-07-22 ノボ ノルディスク アクティーゼルスカブ 遅延作用プロファイルを有するｇｌｐ−１のｇｌｐ−１誘導体及びエキセンジン
JP2002526554A (ja) 1998-10-07 2002-08-20 メディカル カレッジ オブ ジョージア リサーチ インスティチュート，インコーポレイテッド 骨親和性ホルモンとして用いられるグルコース依存性インスリン親和性ペプチド
DE69922043T2 (de) 1998-12-07 2005-11-24 Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. Glp-1 analoge
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
PT1171465E (pt) 1999-03-29 2004-12-31 Uutech Ltd Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes
GB0404124D0 (en) * 2004-02-25 2004-03-31 Univ Ulster Antagonists of GIP
BR0116024A (pt) 2000-12-07 2005-12-13 Lilly Co Eli Proteìna de fusão heteróloga e uso da mesma
US20030232761A1 (en) 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20050059605A1 (en) 2003-01-31 2005-03-17 Krishna Peri Chemically modified metabolites of regulatory peptides and methods of producing and using same
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
BRPI0606992A2 (pt) 2005-02-11 2009-07-28 Amylin Pharmaceuticals Inc análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
WO2007109354A2 (en) 2006-03-21 2007-09-27 Amylin Pharmaceuticals, Inc. Peptide-peptidase inhibitor conjugates and methods of using same
AU2007284365A1 (en) * 2006-08-17 2008-02-21 Amylin Pharmaceuticals, Inc. DPP-IV resistant GIP hybrid polypeptides with selectable properties
WO2010016936A1 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
US8450266B2 (en) 2008-08-07 2013-05-28 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide
KR101417873B1 (ko) 2008-08-07 2014-07-09 입센 파마 에스.에이.에스 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 유사체
AU2009280021B2 (en) 2008-08-07 2012-10-04 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
JP2011530507A (ja) 2008-08-07 2011-12-22 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ グルコース依存性インスリン分泌刺激ポリペプチドアナログ
EP2528618A4 (en) 2010-01-27 2015-05-27 Univ Indiana Res & Tech Corp GLUCAGON ANTAGONISTE AND GIP AGONISTS CONJUGATES AND COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES AND ADIPOSITAS
US9023986B2 (en) 2010-10-25 2015-05-05 Hoffmann-La Roche Inc. Glucose-dependent insulinotropic peptide analogs
SG191252A1 (en) * 2010-12-22 2013-07-31 Marcadia Biotech Inc Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
WO2012167744A1 (en) 2011-06-10 2012-12-13 Beijing Hanmi Pharmaceutical Co., Ltd. Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
US20140377171A1 (en) * 2011-06-10 2014-12-25 Jean Claude Reubi Imaging and Treatment of Neuroendocrine Tumors with Glucose - Dependent Insulinotropic Polypeptide or Analogues or Antagonists Thereof
CN105324125A (zh) 2013-03-15 2016-02-10 印第安纳大学研究及科技有限公司 具有长效的前体药物
US10968266B2 (en) * 2014-09-05 2021-04-06 University Of Copenhagen GIP peptide analogues
US10253078B2 (en) * 2014-10-29 2019-04-09 Zealand Pharma A/S GIP agonist compounds and methods
WO2016205488A1 (en) 2015-06-17 2016-12-22 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
WO2018069442A1 (en) * 2016-10-12 2018-04-19 University Of Copenhagen Peptide dual agonists of gipr and glp2r
WO2018124009A1 (ja) 2016-12-26 2018-07-05 花王株式会社 低体温改善剤
CN110087686A (zh) 2016-12-26 2019-08-02 花王株式会社 认知功能改善剂
CN110139672A (zh) 2016-12-26 2019-08-16 花王株式会社 运动调节功能提高剂
PL3630806T3 (pl) 2017-05-31 2024-05-13 The University Of Copenhagen Analogi peptydów gip o długotrwałym działaniu

Similar Documents

Publication Publication Date Title
JP2020521784A5 (https=)
JP7605747B2 (ja) 修飾されたｇｉｐペプチド類似体
JP7658877B2 (ja) インクレチン類似体およびその使用
KR102440323B1 (ko) 인크레틴 유사체 및 그의 용도
JP5986550B2 (ja) Ｎ末端において修飾されたグルコース依存性インスリン分泌刺激ポリペプチド（ｇｉｐ）のアナログ
RU2485135C2 (ru) Соединения оксинтомодулина (варианты), фармацевтическая композиция на их основе, способы лечения и профилактики ожирения и сопутствующих заболеваний (варианты) и лекарственное средство (варианты)
DK2320923T3 (en) Truncated analogues of glucose-dependent insulinotropic polypeptide
JP2013518115A5 (https=)
JP2011524420A5 (https=)
KR20150131213A (ko) 인슐린-인크레틴 접합체들
JP2014141500A (ja) グルカゴン／ｇｌｐ−１受容体コアゴニスト
HUE028072T2 (en) GIP-based agonists for the treatment of metabolic disease and obesity
KR20120123443A (ko) 대사 장애 및 비만 치료용 글루카곤 길항제-ｇｉｐ 항진제 콘쥬게이트
US20180280480A1 (en) Compositions and peptides having dual glp-1r and glp-2r agonist activity
JP2013510829A (ja) 長時間作用型ｙ２受容体アゴニスト
JP2007001987A5 (https=)
JP2013505221A (ja) 長時間作用性ｙ２受容体アゴニスト
CN110691788B (zh) 长效gip肽类似物
JPWO2020115048A5 (https=)
CA2551039C (en) Analogues of glp-1
JPWO2021110845A5 (https=)
RU2817673C2 (ru) Модифицированные аналоги GIP пептида
CA3230220A1 (en) Gip receptor agonist and use thereof
RU2025116817A (ru) Новый тройной агонист рецепторов GLP-1/GIP/глюкагонового рецептора и содержащая его фармацевтическая композиция для предупреждения или лечения ожирения
RU2021119336A (ru) Модифицированные аналоги GIP пептида